Ken Grauer, MD

SEPTEMBER 21, 2024

The ECG in Figure-1 was obtained from a previously healthy man in his early 20s — who initially presented with GI symptoms, that then evolved into CP ( C hest P ain ). The patient was thought to have anxiety. QUESTIONS: Given the above history — How would YOU interpret the initial ECG that is shown in Figure-1 ? Does the patient's age infuence your interpretation?

Chest Pain 112

Chest Pain Blog Thrombosis Tachycardia 112

HCPLive

SEPTEMBER 21, 2024

Oral vitamin D improves vitamin D status and quality of life in IBS patients but does not significantly reduce symptom severity, a new study suggests.

Quality of Life 95

Quality of Life 95

International Journal of Cardiovascular Sciences

SEPTEMBER 21, 2024

On September 21, 2024, during the Brazilian Congress of Cardiology, an important meeting was held with the reviewers of the ABC Family, which includes the journals Arquivos Brasileiros de Cardiologia (ABC Cardiol), International Journal of Cardiovascular Sciences (IJCS), Arquivos Brasileiros de Cardiologia Imagem Cardiovascular (ABC Imagem), and ABC Heart Failure & Cardiomyopathy (ABC HF).

Article 52

Article Heart Failure Cardiomyopathy 52

HCPLive

SEPTEMBER 21, 2024

This conference talk was titled Acute & Chronic Spontaneous Urticaria: Diagnostic and Therapeutic Strategies and presented a challenging case series to attendees.

59

59

Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Patient Care

The American Journal of Cardiology

SEPTEMBER 21, 2024

Publication date: Available online 20 September 2024 Source: The American Journal of Cardiology Author(s): Agostina M. Fava, Zoran B Popovic, Alaa Alashi, Maran Thamilarasan, Bo Xu, Milind Y.

Exercise 40

Exercise Cardiomyopathy 40

HCPLive

SEPTEMBER 21, 2024

Test your knowledge of the phase 3 MAESTRO-NASH trial supporting resmetirom (Rezdiffra)’s FDA accelerated approval for MASH with this quiz.

52

52

NEJM Journal Watch - Cardiology

SEPTEMBER 21, 2024

Cryoablation bested sham ablation in patients with paroxysmal or persistent AF.

Ablation 40

Ablation Atrial Fibrillation 40